Exploration of Nirmatrelvir Derivatives as Optimized SARS-CoV-2 Antivirals.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42580866

Banumathi Sankaran; Benjamin W Neuman; Chia-Chuan D Cho; Demonta Coleman; Kai S Yang; Kaustav Khatua; Lauren R Blankenship; Sathish Kumar; Shiqing Xu; Veerabhadra R Vulupala; Wenshe Ray Liu; Xuejiao Guo; Yugendar R Alugubelli; Zhi Zachery Geng

Aug 12, 2026